Roche says Herceptin with Pertuzumab "impressive"
5/30/2008
Roche Holding AG's Herceptin combined
with Pertuzumab showed "impressive results" in a Phase II
breast cancer trial, the Swiss drugmaker said on Friday.
More: - Continued here
Post Comment
Entry 1 of 16100
Last Page | Next Page









